Table 1.
KEGG enrichment analysis for 33 new candidate TFs
| Term | Genes | p value | Benjamini |
|---|---|---|---|
| hsa05200: Pathways in cancer | E2F3, TCF7, PPARD, JUN, RXRA, SMAD3, RARB, GLI2, MYC |
5.88E−07 | 2.29E−05 |
| hsa05223: Non-small cell lung cancer | E2F3, RXRA, RARB, FOXO3 |
3.79E−04 | 0.007373 |
| hsa04310: Wnt signaling pathway | TCF7, PPARD, JUN, SMAD3, MYC |
5.93E−04 | 0.00768 |
| hsa05210: Colorectal cancer | TCF7, JUN, SMAD3, MYC |
0.001388 | 0.013451 |
| hsa05222: Small cell lung cancer | E2F3, RXRA, RARB, MYC |
0.001388 | 0.013451 |
| hsa05216: Thyroid cancer | TCF7, RXRA, MYC | 0.002739 | 0.021169 |